In vitro #diagnostics very slow in entering the market. WHY? Delays go about upscaling difficulties, risk & profit, complexity of biology. ‘And probably we need more #women in the field too!’, says professor Joanne Macdonald, the only female at the panel discussion DIATECH 2020

We're closing #DIATECH2020 with a visit to the @LeuvenU library. Thank you all for a nice conference and see you next time! #Leuven

TODAY!!! #RareDiseaseDay show your rare, show you care. Join the #WalkForTTP. From KU Leuven Kulak to az groeninge.

We are starting our #walkforttp celebrating #rarediseaseday. KU Leuven Kulak az groeninge Rode Kruis-Vlaanderen @SanofiGenzyme 📰 Nieuws uit Kortrijk

We do not know how strong we are until being strong is your only choice. #ttpcommunity #rarediseaseday az groeninge

Here is where TTP patients receive their therapy. #ttpcommunity #RareDiseaseDay az groeninge

Listening to testimonies from patients from the #ttpcommunity, researchers, and physicians. #RareDiseaseDay az groeninge

A closer look of the blood. #ttpcommunity #RareDiseaseDay KU Leuven Kulak

Prof. Karen Vanhoorelbeke from Laboratory for Thrombosis Research giving an overview about research on TTP. KU Leuven Kulak #rarediseaseday2020

The voice of the patients #ttpcommunity #RareDiseaseDay

Vicerector Piet Desmet from KU Leuven Kulak telling the #ttpcommunity “You never walk alone”. Laboratory for Thrombosis Research #rarediseaseday2020

The major from 📰 Nieuws uit Kortrijk Vincent Van Quickenborne, supporting the #WalkForTTP initiative from the #ttpcommunity. Laboratory for Thrombosis Research #rarediseaseday2020

A lovely #RareDiseaseDay for the #WalkForTTP. Laboratory for Thrombosis Research KU Leuven Kulak 📰 Nieuws uit Kortrijk az groeninge Rode Kruis-Vlaanderen @SanofiGenzyme UZ Leuven KU Leuven

COVID19 and TTP - TTP Network ttpnetwork.org.uk/covid19-and-tt…

Great collaborative work by the Vanhoorelbeke-team KU Leuven Kulak and Andres Mannik's cloning factory Icosagen. Nicely executed by star PhD student Kadri Kangro of PROFILE H2020 onlinelibrary.wiley.com/doi/full/10.10…

Currently-published epitope mapping data of anti-ADAMTS13 autoantibodies in iTTP is broad due to the use of large protein fragments. Learn how Karen Vanhoorelbeke and colleagues fine-mapped these epitopes in 18 patients with iTTP. Results ➡️ onlinelibrary.wiley.com/doi/full/10.10… KU Leuven Jan Voorberg

6 non-overlapping fragments of ADAMTS13 were used to develop and validate a fine epitope mapping ELISA of autoantbodies in iTTP. This high-throughput assay may be used in future clinical studies. Read more at #RPTH: onlinelibrary.wiley.com/doi/full/10.10… Karen Vanhoorelbeke KU Leuven Jan Voorberg

Very well moderated Q&A session by Ilaria Mancini on the session of Thrombotic Microangiopathies at ISTH. bogac ercig Karen Vanhoorelbeke PROFILE H2020

Thanks Marie Scully for highlighting our paper on #ADAMTS13 #TTP @ITNProfile KU Leuven Kulak Icosagen Transforming the major autoantibody site on ADAMTS13: spacer domain variants retaining von Willebrand factor cleavage activity | Haematologica haematologica.org/article/view/1…

Congratulations Johana Hridinova with an excellent #PhD defence! Very nice discussions on etiology and treatment of iTTP @ITN_Profile UvA Amsterdam Maastricht UMC+ Sanquin KU Leuven